Expression and characterization of a dopamine D4R variant associated with delusional disorder

FEBS Letters

Volumn 422, Issue 2, 1998, Pages 146-150

  Zenner, Marie Thérèse ^a   Nobile, Maria ^b   Henningsen, Robert ^a,e   Smeraldi, Enrico ^b   Civelli, Olivier ^c   Hartman, Deborah S ^a,d   Catalano, Marco ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Hoffman La Roche Department of Metabolic Diseases   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antidepressant; Antipsychotic; DFR1; Polymorphism; Schizophrenia

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; ADRENALIN; APOMORPHINE; BROMOCRIPTINE; BUTACLAMOL; CHLORPROMAZINE; CLOMIPRAMINE; CLONIDINE; CLOZAPINE; DOPAMINE; DOPAMINE 4 RECEPTOR; DOXEPIN; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; LISURIDE; LOXAPINE; MIANSERIN; NORADRENALIN; PIMOZIDE; QUINPIROLE; RACLOPRIDE; RISPERIDONE; SEROTONIN; SPIPERONE; SULPIRIDE; THIORIDAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CLONE; CELL LINE; CHO CELL; CONTROLLED STUDY; DELUSION; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; EXON; GENE EXPRESSION; GENE TRANSFER; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; TANDEM REPEAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; CHO CELLS; CLOZAPINE; CRICETINAE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EPINEPHRINE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; KINETICS; NOREPINEPHRINE; POLYMORPHISM, GENETIC; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RECOMBINANT PROTEINS; SCHIZOPHRENIA, PARANOID; TRANSFECTION; VARIATION (GENETICS);

ANIMALIA;

EID: 0032579206     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)01617-7     Document Type: Article

References (17)

1. Hartman D.S., Civelli O. Ann. Med. 28:1996;211.
2. Catalano M., Nobile M., Novelli E., Nothen M.M., Smeraldi E. Biol. Psychiatry. 34:1993;459.
3. Seeman P., Ulpian C., Chouinard G., Van Tol H.H.M., Dwosh H., Lieberman J.A., Siminovitch K., Liu I.S., Waye J., Voruganti P., Hudson C., Serjeant G.R., Masibay A.S., Seeman M.V. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 54:1994;384.
4. Nothen M.M., Cichon S., Hemmer S., Hebebrand J., Remschmidt H., Lehmkuhl G., Poustka F., Schmidt M., Catalano M., Fimmers R., Korner J., Rietschel M., Propping P. Hum. Mol. Genet. 3:1994;2207.
5. Cichon S., Nöthen M.M., Catalano M., Di Bella D., Maier W., Lichtermann D., Minges J., Albus M., Borrmann M., Franzek E., Stober G., Weigelt B., Korner J., Rietschel M., Propping P. Psychiatr. Genet. 5:1995;97.
6. Kendler K.S. Arch. Gen. Psychiatry. 37:1980;699.
7. Winokur G. Comp. Psychiatry. 18:1977;511.
8. Segal J.H. Am. J. Psychiatry. 146:1989;1261.
9. Spitzer M. Psychiatr. Ann. 22:1992;252.
10. Van Tol H.H.M., Wu C.M., Guan H.-C., Ohara K., Bunzow J.R., Civelli O., Kennedy J., Seeman P., Niznik H.B., Jovanovic V. Nature. 358:1992;149.
11. Lanau F., Brockhaus M., Pink J.R.L., Franchet C., Wildt-Perinic D., Goepfert C., Probst A., Hartman D.S. J. Neurochem. 69:1997;2169.
12. Lanau F., Zenner M.-T., Civelli O., Hartman D.S. J. Neurochem. 68:1997;804.
13. Lichter J.B., Barr C.L., Kennedy J.L., Van Tol H., Kidd K.K., Livak K.J. Hum. Mol. Genet. 2:1993;767.
14. Newman-Tancredi A., Audinot-Bouchez V., Gobert A., Millam M.J. Eur. J. Pharmacol. 319:1997;379.
15. Bristow L.J., Kramer M.S., Kulagowski J., Patel S., Ragan C.I., Seabrook G.R. Trends Pharmacol. Sci. 18:1997;186.
16. Austin L.S., Lydiard R.B., Ballenger J.C., Cohen B.M., Laraia M.T., Zealberg J.J., Fossey M.D., Ellinwood E.H. Biol. Psychiatry. 30:1991;225.
17. Ashgari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H.M. J. Neurochem. 65:1995;1157.